Literature DB >> 2303648

Serum IgE and human immunodeficiency virus (HIV) infection.

D N Wright1, R P Nelson, D K Ledford, E Fernandez-Caldas, W L Trudeau, R F Lockey.   

Abstract

Human immunodeficiency virus infection is characterized by a progressive depletion of helper T-lymphocytes and, like allergic diseases, is associated with altered T cell regulation. Total serum IgE was measured in 67 infected male subjects, 27 uninfected heterosexual male subjects, and 18 uninfected homosexual male subjects. The mean IgE level (132 IU/ml) of infected subjects with a helper T-lymphocyte number less than or equal to 200/mm3 was significantly greater than mean IgE levels of the uninfected heterosexual (38 IU/ml) and homosexual (35 IU/ml) groups. IgE levels were inversely related to both helper T cell and suppressor/cytotoxic T cell numbers but not to IgG or IgA levels. The increase in IgE was not a reflection of an increased prevalence of atopic disease (allergic asthma, allergic rhinitis, or atopic dermatitis) in the infected subjects. The elevation of IgE may be related to a difference among the groups in T cell production of IgE regulatory lymphokines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303648     DOI: 10.1016/0091-6749(90)90154-v

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

Review 1.  HIV and asthma, is there an association?

Authors:  Jessica A Kynyk; Jonathan P Parsons; Michael F Para; Susan L Koletar; Philip T Diaz; John G Mastronarde
Journal:  Respir Med       Date:  2012-01-27       Impact factor: 3.415

2.  Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

Authors:  E E Nakayama; Y Hoshino; X Xin; H Liu; M Goto; N Watanabe; H Taguchi; A Hitani; A Kawana-Tachikawa; M Fukushima; K Yamada; W Sugiura; S I Oka; A Ajisawa; H Sato; Y Takebe; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Diagnosis of human immunodeficiency virus infection using an immunoglobulin E-based assay.

Authors:  M Fletcher; M J Miguez-Burbano; G Shor-Posner; V Lopez; H Lai; M K Baum
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

Review 4.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

5.  Cold urticaria, raised IgE and HIV infection.

Authors:  R C Yu; B Evans; J J Cream
Journal:  J R Soc Med       Date:  1995-05       Impact factor: 5.344

Review 6.  Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.

Authors:  M Bradley Drummond; Ken M Kunisaki; Laurence Huang
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

Review 7.  The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

Review 8.  HIV-1 induced AIDS is an allergy and the allergen is the Shed gp120--a review, hypothesis, and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

9.  Human cytomegalovirus (HCMV)-specific immunoglobulin E as a serologic marker for HCMV infection in immunocompromised patients.

Authors:  B Weber; W Braun; B Tyralla; A Hamann; H W Doerr
Journal:  Clin Investig       Date:  1992-06

10.  Serum IgE levels of tuberculosis patients in a tropical setup with high prevalence of HIV and intestinal parasitoses.

Authors:  A Kassu; A Mohammad; Y Fujimaki; F Moges; D Elias; F Mekonnen; G Mengistu; M Yamato; Y Wondmikun; F Ota
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.